Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor monoclonal …

R Puri, V Mehta, PB Duell, D Nair, JC Mohan… - Journal of clinical …, 2020 - Elsevier
Background Rates of atherosclerotic cardiovascular disease (ASCVD) are strikingly high in
India compared to Western countries and are increasing. Moreover, ASCVD events occur at …

[PDF][PDF] Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor …

NN Khanna, AP DM, RM DM, AK DM, S Puri… - Journal of Clinical …, 2020 - academia.edu
BACKGROUND: Rates of atherosclerotic cardiovascular disease (ASCVD) are strikingly
high in India compared to Western countries and are increasing. Moreover, ASCVD events …

Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor monoclonal …

R Puri, V Mehta, J Yusuf, S Mukhopadhyay… - Journal of Clinical …, 2020 - elibrary.ru
The authors express great appreciation for the 162 expert health care providers throughout
India who thoughtfully provided essential input that contributed to the formulation of this …

[PDF][PDF] Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor …

NN Khanna, S Puri, A Muruganathan… - Journal of Clinical …, 2020 - researchgate.net
BACKGROUND: Rates of atherosclerotic cardiovascular disease (ASCVD) are strikingly
high in India compared to Western countries and are increasing. Moreover, ASCVD events …

Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor monoclonal …

R Puri, V Mehta, PB Duell, D Nair… - Journal of clinical …, 2020 - ohsu.elsevierpure.com
Background: Rates of atherosclerotic cardiovascular disease (ASCVD) are strikingly high in
India compared to Western countries and are increasing. Moreover, ASCVD events occur at …

Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor monoclonal …

R Puri, V Mehta, PB Duell, D Nair… - Journal of Clinical …, 2020 - europepmc.org
Background Rates of atherosclerotic cardiovascular disease (ASCVD) are strikingly high in
India compared to Western countries and are increasing. Moreover, ASCVD events occur at …

Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor monoclonal …

R Puri, V Mehta, PB Duell, D Nair… - Journal of clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Rates of atherosclerotic cardiovascular disease (ASCVD) are strikingly high in
India compared to Western countries and are increasing. Moreover, ASCVD events occur at …

Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor monoclonal …

R Puri, V Mehta, PB Duell, D Nair… - Journal of Clinical …, 2020 - lipidjournal.com
Background Rates of atherosclerotic cardiovascular disease (ASCVD) are strikingly high in
India compared to Western countries and are increasing. Moreover, ASCVD events occur at …

[PDF][PDF] Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor …

NN Khanna, AP DM, RM DM, AK DM, S Puri… - Journal of Clinical …, 2020 - academia.edu
BACKGROUND: Rates of atherosclerotic cardiovascular disease (ASCVD) are strikingly
high in India compared to Western countries and are increasing. Moreover, ASCVD events …